Replies to post #192550 on Biotech Values

[lgonber]

Let me know, your earlier comments in this stock made me more cautious, so that is one of the reasons I decided to leave at $40. Also, insider "planed" sales...might be better entry now...thanks

[DewDiligence]

AAVL—Astute observation by ‘poorgradstudent’ in reply to my post about AMD being a challenging target for gene therapy:

@DewDiligence A contributor to this problem (across diseases, not just AMD) is that mouse models often make diseases *seem* monogenic.

— Ozgur Ogut (@Ogut_Ozgur) June 15, 2015

The stock is now -37% in AH trading.